Exposure to belimumab in the first trimester of pregnancy in a young woman with systemic lupus erythematosus Ignacio Javier Gandino, Sophia Lutgen, María Cristina Basta, Sebastián Andrés Muñoz

Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández, Carlos Marras Fernández-Cid, Jose Luis Andreu Sánchez, Jaime Calvo Alén, Angel M. García-Aparicio, Elvira Díez Álvarez, Francisco Javier Hidalgo Bermejo, Carlos Coronell, Alessandra Perna, Josep Ordi Ros

Comment on “Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology” Juan Manuel Mejia-Vilet, Javier Tejeda-Maldonado, Ricardo Correa-Rotter